Status:
COMPLETED
V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Staphylococcal Infection
Eligibility:
MALE
20-80 years
Phase:
PHASE1
Brief Summary
This study is to evaluate the safety and immunogenicity of V710 in Japanese male subjects.
Eligibility Criteria
Inclusion
- Generally Good Physical Health
Exclusion
- Received V710 Vaccine, Any Other Investigational S. Aureus Vaccine, Or Investigational S. Aureus Antibodies Before
- Temperature Of Equal/Greater Than 100.4 Degrees F(38 Degrees C) Within The Past 48 Hours
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00735839
Start Date
March 1 2008
End Date
June 1 2008
Last Update
December 21 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.